Ray Evan C, Abdel-Kader Khaled, Bircher Nicholas, Rondon-Berrios Helbert
Renal-Electrolyte Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Division of Nephrology and Hypertension, Vanderbilt University, Nashville, Tennessee.
Physiol Rep. 2015 Sep;3(9). doi: 10.14814/phy2.12560.
The safety of contemporary volatile anesthetic agents with respect to kidney function is well established, and growing evidence suggests that volatile anesthetics even protect against ischemic nephropathy. However, studies examining effects of volatile anesthetics on kidney function frequently demonstrate transient proteinuria and glycosuria following exposure to these agents, although the cause of these findings has not been thoroughly examined. We describe the case of a patient who underwent a neurosurgical procedure, then experienced glycosuria without hyperglycemia that resolved within days. Following a second neurosurgical procedure, the patient again developed glycosuria, now associated with ketonuria. Further examination demonstrated nonalbuminuric proteinuria in conjunction with urinary wasting of phosphate and potassium, indicative of proximal tubule impairment. We suggest that transient proximal tubule impairment may play a role in the proteinuria and glycosuria described following volatile anesthetic exposure and discuss the relationship between these observations and the ability of these agents to protect against ischemic nephropathy.
当代挥发性麻醉剂对肾功能的安全性已得到充分证实,越来越多的证据表明挥发性麻醉剂甚至可预防缺血性肾病。然而,研究挥发性麻醉剂对肾功能影响的研究经常表明,接触这些药物后会出现短暂的蛋白尿和糖尿,尽管这些发现的原因尚未得到彻底研究。我们描述了一名患者的病例,该患者接受了神经外科手术,随后出现了无高血糖的糖尿,数天内自行缓解。在第二次神经外科手术后,患者再次出现糖尿,此时伴有酮尿。进一步检查发现非白蛋白尿性蛋白尿,同时伴有磷酸盐和钾的尿流失,提示近端肾小管受损。我们认为,短暂的近端肾小管损伤可能在挥发性麻醉剂暴露后出现的蛋白尿和糖尿中起作用,并讨论这些观察结果与这些药物预防缺血性肾病能力之间的关系。